Investors seeking all of the latest and greats stock market stories for Friday will find them in our daily roundup. ...

The company’s racing to get its newest obesity drug to market. ...

Danish drugmaker Novo Nordisk ($NVO) launched its blockbuster diabetes treatment Ozempic (semaglutide injection) in India at an entry price of $24.......

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk today and set a price target of DKK475.00. Papadakis covers the He......

UBS analyst Matthew Weston maintained a Hold rating on Novo Nordisk today and set a price target of DKK295.00. According to TipRanks, Weston is a 4......

The pharma giant has high hopes for the medication. ...

Hims & Hers Health ($HIMS) is strengthening its position in the UK with the launch of weight-loss programs. This launch will also include the offic......

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk today and set a price target of DKK352.00. Quigley covers the Healthcar......

Biotech Structure Therapeutics’ ($GPCR) shares rallied 102.49% on Monday after mid-stage data for its obesity pill topped competing offerings from ......

Shares of Texas-based biotech firm iBio ($IBIO) have climbed as high as 50% over the past 24 hours. This follows a 39.17% gain on Monday and an add......